EUVIMEDEUVIMED entdecken
Open Access

HIV-1 Tat Upregulates TREM1 Expression in Human Microglia

Grant R Campbell iD, Pratima Rawat, Rachel K To iD, Stephen A Spector iD

The Journal of Immunology · 01.08.2023 · 211 (3) · 429-442

DOI: 10.4049/jimmunol.2300152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 01.08.2023. Verfasst von Grant R Campbell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD. Hauptthemen laut MEDLINE: HIV-1, HIV Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIMH NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Because microglia are a reservoir for HIV and are resistant to the cytopathic effects of HIV infection, they are a roadblock for any HIV cure strategy. We have previously identified that triggering receptor expressed on myeloid cells 1 (TREM1) plays a key role in human macrophage resistance to HIV-mediated cytopathogenesis. In this article, we show that HIV-infected human microglia express increased levels of TREM1 and are resistant to HIV-induced apoptosis. Moreover, upon genetic inhibition of TREM1, HIV-infected microglia undergo cell death in the absence of increased viral or proinflammatory cytokine expression or the targeting of uninfected cells. We also show that the expression of TREM1 is mediated by HIV Tat through a TLR4, TICAM1, PG-endoperoxide synthase 2, PGE synthase, and PGE2-dependent manner. These findings highlight the potential of TREM1 as a therapeutic target to eradicate HIV-infected microglia without inducing a proinflammatory response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsHumansTriggering Receptor Expressed on Myeloid Cells-1MicrogliaMacrophages

Substanzen

Triggering Receptor Expressed on Myeloid Cells-1TREM1 protein, human

Autor:innen und Institutionen

  • Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD.
  • Division of Infectious Diseases, Department of Pediatrics, University of California San Diego, La Jolla, CA.
  • Rady Children's Hospital, San Diego, CA.

ORCID-Profile: Grant R Campbell, Rachel K To, Stephen A Spector

Förderung

  • NIAID NIH HHS
  • NIMH NIH HHS
  • NINDS NIH HHS
  • HHS | NIH | National Institute of Mental Health
  • HHS | NIH | National Institute of Neurological Disorders and Stroke
  • University of South Dakota
  • International Maternal Pediatric Adolescent AIDS Clinical Trials Network

Zitieren

APA

Campbell, G. R., Rawat, P., To, R. K., & Spector, S. A. (2023). HIV-1 Tat Upregulates TREM1 Expression in Human Microglia. The Journal of Immunology, 211(3), 429-442. https://doi.org/10.4049/jimmunol.2300152

Vancouver

Campbell GR, Rawat P, To RK, Spector SA. HIV-1 Tat Upregulates TREM1 Expression in Human Microglia. The Journal of Immunology. 2023;211(3):429-442. doi:10.4049/jimmunol.2300152

BibTeX
@article{Campbell2023,
  author = {Campbell, Grant R and Rawat, Pratima and To, Rachel K and Spector, Stephen A},
  title = {HIV-1 Tat Upregulates TREM1 Expression in Human Microglia},
  journal = {The Journal of Immunology},
  year = {2023},
  volume = {211},
  number = {3},
  pages = {429--442},
  doi = {10.4049/jimmunol.2300152}
}
Kostenlos starten →